Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection

<div>The BLCA-4 serum levels (ng/mL) of non-muscle-invasive bladder cancer (NMIBC) patients compared with benign prostatic hyperplasia (BPH) and normal individuals.</div>

Disease Markers

fig3

Figure 3

Figure 3: Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection 